FBXO38 Inhibitors
In the cellular environment, FBXO38 inhibitors exert their influence by modulating various biochemical pathways that are integral to the protein's function. One mechanism involves the inhibition of the proteasome, a complex responsible for degrading ubiquitinated proteins. By impeding this process, the inhibitors lead to an accumulation of proteins that are otherwise targeted for degradation by FBXO38, thus indirectly diminishing its regulatory role in protein turnover. Another approach to inhibiting FBXO38 involves obstructing the neddylation process, which is essential for the activation of cullin-RING E3 ubiquitin ligases, a group to which FBXO38 belongs. This disruption results in a cascade effect, culminating in the functional inhibition of FBXO38 by preventing it from properly tagging proteins for degradation.
Additional strategies to inhibit FBXO38 include the modulation of autophagy pathways and the manipulation of substrate recognition by cullin-RING E3 ligases. Autophagy inhibitors lead to the accumulation of substrates within cells, potentially interfering with FBXO38's ability to target these proteins for degradation. Moreover, compounds that alter the substrate recognition of cullin-RING E3 ligases can indirectly affect FBXO38's ubiquitination activity, leading to an inhibition of its function. Oxidative stress inducers also play a role by affecting the redox regulation of proteins, which could indirectly impact FBXO38's activity. Additionally, cell cycle regulation can be influenced by stabilizing p53, resulting in increased expression of cell cycle inhibitors, thereby potentially affecting FBXO38's role in this process.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that prevents the degradation of ubiquitinated proteins, indirectly inhibiting FBXO38 by stabilizing its substrates and potentially disrupting its regulatory functions. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
A NEDD8-activating enzyme inhibitor that impairs the neddylation process, consequently affecting the function of cullin-RING ligases (CRLs) to which FBXO38 belongs, leading to substrate accumulation and functional inhibition of FBXO38. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
An irreversible inhibitor of ubiquitin-activating E1 enzyme, leading to reduced ubiquitination and degradation of proteins, thereby indirectly inhibiting the substrate turnover function of FBXO38. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
An autophagy inhibitor that can result in the accumulation of autophagic substrates, potentially interfering with FBXO38's ability to target proteins for degradation. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A specific inhibitor of the 20S proteasome that can lead to the accumulation of polyubiquitinated proteins, indirectly affecting the functional activity of FBXO38 by stabilizing potential substrates. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor used to block the degradation of polyubiquitinated proteins, indirectly inhibiting FBXO38's role in protein turnover. | ||||||
CC-122 | 1015474-32-4 | sc-507488 | 5 mg | $420.00 | ||
A cereblon modulator that affects the function of cullin-RING E3 ligases by hijacking the substrate recognition, which may indirectly affect FBXO38's ubiquitination activity. | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
A thioredoxin reductase inhibitor that can induce oxidative stress, potentially affecting the redox regulation of proteins and indirectly affecting FBXO38 function. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
A selective proteasome inhibitor that can lead to the accumulation of FBXO38 substrates by preventing their degradation. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
A MDM2 antagonist that stabilizes p53, leading to increased expression of p21 which can inhibit cyclin-dependent kinases, potentially affecting FBXO38's role in cell cycle regulation. | ||||||